Small cell lung cancer
Conditions
Interventions
None listed
Sponsors
Kyoto Prefectural University of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females aged 20 years or older, PS: 0-2, with untreated advanced small cell lung cancer who have had a pathological diagnosis of small cell lung cancer confirmed by tumor tissue specimen collection. Patients with chemoradiotherapy can be enrolled if they were diagnosed more than 6 months after the completion of treatment. Concurrent palliative irradiation of the chest is eligible. 2) A patient with evaluable lesions by RECIST (version 1.1). 3) A patient who is to receive immunochemotherapy. 4) A patient who provides written informed consent.
Exclusion criteria
Exclusion criteria: 1) A patient in which evaluation using residual specimens after pathological diagnosis is impossible or difficult. 2) A patient who is judged ineligible to enroll the study by an attending doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival: PFS | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to treatment failure: TTF Overall survival: OS Overall response rate; ORR Disease control rate; DCR Adverse events including immune related adverse events. | — |
Countries
Japan
Contacts
Public ContactKenji Morimoto
University Hospital, Kyoto Prefectural University of Medicine Department of pulmonary medicine
Outcome results
None listed